Clorox (CLX) FY2017 results: revenue $6.0 billion, up 3.7% on the year
Clorox Co. (CLX) reported revenue of $6.0 billion for fiscal 2017, the year ended 30 June 2017, up 3.7% on the year before. Net income was $701 million, up 8.2%, and diluted earnings per share $5.33. The figures are the company's own, from the 10-K it filed with the SEC on 14 August 2018.
Revenue
$6.0 billion
+3.7% on the year
FY2010FY2017
Operating margin
n/a
FY2010FY2017
Net income
$701 million
+8.2% on the year
FY2010FY2017
Diluted EPS
$5.33
+8.3% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
5,973
5,761
5,655
+3.7%
Cost of revenue
3,302
3,163
3,190
+4.4%
Gross profit
2,671
2,598
2,465
+2.8%
Gross margin
44.7%
45.1%
43.6%
Research and development
135
141
136
-4.3%
Selling, general and administrative
810
806
798
+0.5%
Interest expense
88.0
88.0
100
0.0%
Pre-tax income
1,033
983
921
+5.1%
Income tax
330
335
315
-1.5%
Effective tax rate
31.9%
34.1%
34.2%
Net income
701
648
580
+8.2%
Net margin
11.7%
11.2%
10.3%
Diluted EPS
$5.33
$4.92
$4.37
+8.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
865
778
874
+11.2%
Capital expenditure
231
172
125
+34.3%
Free cash flow
634
606
749
+4.6%
Free cash flow margin
10.6%
10.5%
13.2%
Cash from investing
-205
-430
-106
Cash from financing
-645
-316
-696
Depreciation and amortisation
163
165
169
-1.2%
Share-based compensation
51.0
45.0
32.0
+13.3%
Buybacks
183
254
434
-28.0%
Dividends paid
412
398
385
+3.5%
Dividend per share
$3.24
$3.11
$2.99
+4.2%
Diluted shares, weighted
132m
132m
133m
-0.1%
Shares outstanding at period end
129m
129m
129m
-0.3%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
542
297
118
+82.5%
Debt
2,195
2,312
2,096
-5.1%
Other liabilities
1,836
1,909
1,940
-3.8%
Total liabilities and equity
4,573
4,518
4,154
+1.2%
Fixed assets
931
906
918
+2.8%
Goodwill
1,196
1,197
1,067
-0.1%
Intangible assets
722
735
585
-1.8%
Cash and equivalents
418
401
382
+4.2%
Receivables
565
569
519
-0.7%
Inventory
459
443
385
+3.6%
Other assets
282
267
298
+5.6%
Total assets
4,573
4,518
4,154
+1.2%
10-K for the year ended 30 June 2017, filed 14 August 2018: the filing.